Recombinant human FGF4 protein

£160.00£1,200.00

Qk004 Recombinant human FGFprotein is a 14 kDa non-glycosylated, bioactive domain of human fibroblast growth factor 4, which has been optimized for expression in E. coliOur recombinant human FGF4 is ideal for applications such as the proliferation and differentiation of embryonic and tissue stem cells, as well as the derivation of organoids from iPSCs and PSCs. 

Fibroblast growth factor 4 (FGF-4) is a member of the FGF superfamily with a physiological role in the regulation of proliferation and differentiation in embryonic stem cells and tissue stem cells1-3.

FGF-4 promotes neural stem cell proliferation and neuronal differentiation in the postnatal brain4, increases the proliferation rate of human adult bone-marrow derived mesenchymal stem cells5 and supports the maintenance, proliferation and self-renewal properties of human embryonic stem cells6.

Synergism between FGF-4 and WNT signalling acts to form hindgut organoids from iPSC-derived human posterior gut endoderm cells7 and FGF-4 is used to mimic embryonic intestinal development during directed differentiation in culture of pluripotent stem cells into intestinal organoids.

Summary: Mature domain of human FGF4 (residues 79-206, Uniprot: P08620) expressed in E. coli and purified to homogeneity. Mature protein is a non-glycosylated protein.

Molecular mass: ~14 kDa

Form: Protein is provided frozen in PBS (carrier protein-free) at 1 mg/ml.

Purity and bioactivity

For peace of mind that our recombinant human FGF-4 protein will work exactly the same way every day, from batch to batch and at any scale you need, we conduct extensive purity and bioactivity analysis, including SDS-PAGE, mass spectrometry, reversed-phase chromatography, UV spectroscopy and endotoxin level testing.

We also work with our collaborators at Stemnovate, a specialist stem cell biotechnology company, to check the final purified protein induces the correct level of proliferation in iPSC culture .

Find out more about our extensive purity testing in the next tab.

Example data

Protein purity: SDS-PAGE in reduced and non-reduced conditions

Recombinant FGF-4 protein purity in SDS-PAGE

Bioactivity: FGF4 induces cell proliferation of iPSC cells (Stemnovate iPSC1 line)

Research applications

iPSC/ESC maintenance

iPSC/ESC differentiation

All our proteins are produced in our Cambridge, UK labs.  We provide detailed quality data for each batch because we believe reliable, high quality cytokines and growth factors are critical for successful stem cell and organoid culture.  Please contact us with questions any time by email at support@qkine.com or phone +44 (0) 1223 491486 / US toll free 1-866 877 2185.

Order online and upload your PO or pay by credit card,  or email your PO to orders@qkine.com.

We provide bulk orders and stock reservation for sensitive applications, please email us.

Our products are for research use only and not for diagnostic or therapeutic use.  Products are not for resale.

For final purity and activity tests on our proteins, we choose a vial at random and reconstitute as recommended.  Biochemical identity and purity is determined using SDS-PAGE, mass spectrometry and analytical reversed-phase chromatography.  Bioactivity is quantified using an appropriate cell-based assay.  As stem cells are sensitive to endotoxin levels, we use a high resolution test to ensure endotoxin levels are at industry-leading low levels (<0.01 EU per µg protein).  We also check that the correct amount of protein is recovered from the vial - it might sound basic but if you order 100 µg, we believe you should receive 100 µg, so when you use the proteins you can rely on your calculated dilution.

Purity: SDS-PAGE

Result: FGF4 migrates as a single band at 14 kDa in non-reducing conditions (NR) and upon reduction (R).  No contaminating protein bands are visible.

Recombinant FGF-4 protein purity in SDS-PAGE

Purified recombinant protein (7 µg) was resolved using 15% w/v SDS-PAGE in reduced (+β-mercaptothanol, R) and non-reduced conditions (NR) and stained with Coomassie Brilliant Blue R250.

Bioactivity: HEK293T proliferation assay

Result: FGF4 induces cell proliferation of HEK293T cells.

Human embryonic kidney cell line 293T (HEK293T) was cultured in serum-free media containing 100ng/ml hFGF2. The number of viable metabolically active cells was detected by ATP measurement using a bioluminescent reaction (n=3; data show mean ± SEM). Data provided by Stemnovate Ltd, Cambridge, UK.

Purity: mass spec analysis

Result: calculated molecular mass of the FGF4 is 14409.8 Da. Result of the analysis: 14278.4 Da which is consistent with the calculated mass.  No significant heterogeneity is present.

MALDI mass spectrometric analysis is used to confirm the molecular mass of the intact protein and to reveal any heterogeneity that would not be evident in SDS-PAGE analysis. The results are compared with calculated mass of the protein with the assumption that all the cysteines are disulfide-linked. The different peaks represent different charge states of the protein.

Purity: endotoxin level determination

Result: Endotoxin level <0.005 EU/ug protein (below level of detection)

Stem cell cultures are sensitive to endotoxins1, which can be present in media, serum and as a contaminant on plasticware.  We optimize our protein production processes to ensure the lowest possible levels of endotoxin contamination.    Our endotoxin pass criteria are set at the industry-leading <0.1 EU per ug protein and we aim for <0.01 EU per ug protein.  Endotoxin levels in our proteins are determined by an external expert microbiological testing services provider.  Example data from Qk001 batch #011

1. A biological study establishing the endotoxin limit for in vitro proliferation of human mesenchymal stem cells (2017). Yusuke Nomura, Chie Fukui, Yuki Morishita, Yuji Haishima. Regenerative Therapy, 7, 45-51.

Result: FGF4 induces cell proliferation of iPSC cells (Stemnovate iPSC1 line).

IPSC (Stemnovate iPSC1) were cultured in serum-free media containing 100ng/ml hFGF4. The number of viable metabolically active cells was detected by ATP measurement using a bioluminescent reaction (n=3; data show mean ± SEM). No media change was performed on day 2 leading to reduced viable cell numbers on day 3. Data provided by Stemnovate Ltd, Cambridge, UK.

Share your thoughts!

Let us know what you think...

What others are saying

There are no contributions yet.

×

Login

Register

Your personal data will be used to support your experience throughout this website, to manage access to your account, and for other purposes described in our privacy policy.

Continue as a Guest

Don't have an account? Sign Up

Thaw the sample on ice, spin briefly and dilute with PBS as needed.  Our proteins are supplied carrier protein-free.  If compatible with your work, add carrier protein of your choice such as BSA, HSA or gelatin to further minimize loss by adsorption.  Spin in a microfuge for 5 minutes at maximum speed, and divide the solution into suitable aliquots and store at -80°C. We recommend that single-use aliquots should be prepared to avoid freeze-thaw cycles.

Every effort is made to ensure samples are sterile however we recommend sterile filtering after dilution in media or the final working solution.

We check that the correct amount of protein is recovered from the vial – it might sound basic but if you order 100 µg, we believe you should receive 100 µg, so when you use the proteins you can rely on your calculated dilution.

Recovery: protein quantitation

Result: UV spectrum shows full recovery of protein following aliquoting and lyophilization.

Absorbance at 280 nm: average 0.068
Recovered concentration: 0.068 cm-1 x 10 / 0.62 cm-1 mg ml-1 = 1.1 mg / ml
Recovery: 110% (>100% due to routine 10% over-fill of vials during aliquoting)

The sample was diluted 1:10 in 100 mM sodium phosphate pH 7.4 and the UV spectrum 340-220 nm measured in duplicate. Concentration was calculated using extinction coefficient at 280 nm

Go to Top